Zevra Therapeutics, Inc. ZVRA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s operating lease ROU assets?
- Zevra Therapeutics, Inc. (ZVRA) reported operating lease ROU assets of 13.1% in Q1 2026.
- How has Zevra Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Zevra Therapeutics, Inc.'s operating lease ROU assets decreased by 100.0% year-over-year, from 163,600,000% to 13.1%.
- What is the long-term trend for Zevra Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s operating lease ROU assets has grown at a -96.0% compound annual growth rate (CAGR), from 135,000,000% to 13%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.